Roche says FDA grants priority review to hemophilia drug emicizumab

5 hours ago
ZURICH (Reuters) - Swiss pharma group Roche said the U.S. Food and Drug Administration (FDA) granted priority review to its emicizumab for hemophilia A with inhibitors.

Latest Life News

More Life News

South Africa's first legal rhino horn auction opens

JOHANNESBURG (Reuters) - South Africa's first legal auction of rhino horns opened for bids on Wednesday and 264 horns went on sale after the owner of the world's biggest private rhino herd won a court case against the government.

23 Aug 2017

Top News Videos